Clinical Trial Update: Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating AzaSite (azithromycin ophthalmic solution) versus vehicle for bacterial conjunctivitis has completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• AZASITE (AZITHROMYCIN MONOHYDRATE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Bacterial Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2011-10-27